30.01.2018 01:22:00
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MetLife, Inc. - MET
NEW YORK, Jan. 29, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of MetLife, Inc. ("MetLife" or the "Company") (NYSE: MET). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.
The investigation concerns whether MetLife and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here to join a class action]
On January 29, 2018, post-market, MetLife announced that it would postpone its fourth-quarter earnings announcement, citing a "material weakness" in its financial reporting. In addition, MetLife advised investors that it expected to increase total reserves between $525 million and $575 million on a pre-tax basis to cover certain annuity recipients "who have been unresponsive or missing over time." On this news, MetLife's share price has fallen sharply in after-hours trading on January 29, 2018.
The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.
CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com
View original content:http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-metlife-inc--met-300589880.html
SOURCE Pomerantz LLP
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu MetLife Inc.mehr Nachrichten
04.02.25 |
Ausblick: MetLife gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net) | |
30.01.25 |
S&P 500-Wert MetLife-Aktie: So viel hätten Anleger an einem MetLife-Investment von vor 10 Jahren verdient (finanzen.at) | |
23.01.25 |
S&P 500-Papier MetLife-Aktie: So viel hätten Anleger an einem MetLife-Investment von vor 5 Jahren verdient (finanzen.at) | |
21.01.25 |
Erste Schätzungen: MetLife öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) | |
16.01.25 |
S&P 500-Papier MetLife-Aktie: So viel Gewinn hätte ein MetLife-Investment von vor 3 Jahren eingefahren (finanzen.at) | |
09.01.25 |
S&P 500-Wert MetLife-Aktie: So viel Gewinn hätte eine MetLife-Investition von vor einem Jahr eingebracht (finanzen.at) | |
02.01.25 |
S&P 500-Titel MetLife-Aktie: So viel Gewinn hätte ein Investment in MetLife von vor 10 Jahren eingefahren (finanzen.at) | |
26.12.24 |
S&P 500-Titel MetLife-Aktie: So viel Gewinn hätte eine MetLife-Investition von vor 5 Jahren eingebracht (finanzen.at) |
Analysen zu MetLife Inc.mehr Analysen
Aktien in diesem Artikel
MetLife Inc. | 81,36 | 0,02% |